Grant Recipients

Alisa Lee Sherick MD

University of Colorado Denver

Targeting MerTK as an immunotherapeutic strategy in pediatric acute myeloid leukemia

Mirian Rosenberg, PhD

Hebrew University of Jerusalem/ The Children's Hospital of Philadelphia

Autoantigen discovery and immune profiling of Opsoclonus Myoclonus Syndrome

Eunice Lopez Fuentes, Ph.D

University of California, San Francisco

Novel combination therapies to target metastatic osteosarcoma based on epigenetic analysis of chromatin accessibility

Funded in Partnership with The Burns Family

Shahrzad Bahrampour , Ph.D

The Hospital for Sick Children, Toronto

Unconventional role of volume-regulated anion channel in pediatric brain tumor

Funded by #ColbyStrong

Aasef G. Shaikh MD,PhD

Functional Electrical Stimulation Institute

Membranes and Models - Towards Targeted Therapy of Opsoclonus

Funded in partnership with The Viswanatha Family + Friends

Inga-Marie Schaefer, MD

Brigham and Women's Hospital

CIC-rearranged sarcoma: biologic mechanisms and therapeutic targeting

Funded in Partnership with #ColbyStrong

Patricia Denise B. Tiburcio, PhD

University of Texas, Southwestern

Targeting Proteasome and mTOR pathways in Actinomycin-Resistant Wilms Tumors

Funded by Funded by Gentleman Toker In Honor of Michelle Laderman

Delfim Duarte, MD PhD

Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal

Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia

Amy Erbe-Gurel, PhD

University of Wisconsin

Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities

Dung-Fang Lee, PhD

The University of Texas Health Science Center

The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma

Vicki Huff, PhD

University of Texas M.D. Anderson Cancer Center

Assessment of a cancer preventive agent for Wilms tumor

Thais Armangue, MD, PhD

Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain

Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling

Grant Funded in Partnership with The Viswanatha Family + Friends

Julien Fleurence PhD, PharmD

Baylor College of Medicine

T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers

Lai Man (Natalie) Wu , PhD

Cincinnati Children’s Hospital Medical Center

Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Supported in part by Hanna's Hoops 4 Healing

Alexandra Stevens, MD, PhD

Baylor College of Medicine

Predicting Atovaquone-Induced Apoptosis in Pediatric AML

Grant Rowe, MD PhD

Children’s Hospital Boston

Targeting leukemia stem cells in infant B-lymphoblastic leukemia

This grant is funded by Change a Life Foundation

Laura Perin, PhD

Children's Hospital Los Angeles

Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?

Surinder Kumar, PhD

University of Michigan

The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma

This grant is funded by Peloton Magazine